Literature DB >> 3025147

Oxetanocin, a novel nucleoside from bacteria.

N Shimada, S Hasegawa, T Harada, T Tomisawa, A Fujii, T Takita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3025147     DOI： 10.7164/antibiotics.39.1623

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  20 in total

Review 1.  Bioactive cyclobutane-containing alkaloids.

Authors:  Valery M Dembitsky
Journal:  J Nat Med       Date:  2007-09-05       Impact factor: 2.343

Review 2.  Recent examples of novel secondary metabolites.

Authors:  A G Brown
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

3.  Biosynthesis of Oxetanocin-A Includes a B12-Dependent Radical SAM Enzyme That Can Catalyze both Oxidative Ring Contraction and the Demethylation of SAM.

Authors:  Aoshu Zhong; Yu-Hsuan Lee; Yung-Nan Liu; Hung-Wen Liu
Journal:  Biochemistry       Date:  2021-02-09       Impact factor: 3.162

4.  Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds.

Authors:  J Seki; N Shimada; K Takahashi; T Takita; T Takeuchi; H Hoshino
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

5.  Synthesis and anti-HIV activity of D- and L-thietanose nucleosides.

Authors:  Hyunah Choo; Xin Chen; Vikas Yadav; Jianing Wang; Raymond F Schinazi; Chung K Chu
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

6.  An HD domain phosphohydrolase active site tailored for oxetanocin-A biosynthesis.

Authors:  Jennifer Bridwell-Rabb; Gyunghoon Kang; Aoshu Zhong; Hung-Wen Liu; Catherine L Drennan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

7.  Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G.

Authors:  Y Nishiyama; N Yamamoto; K Takahash; N Shimada
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 8.  Development of novel drugs from marine surface associated microorganisms.

Authors:  Anahit Penesyan; Staffan Kjelleberg; Suhelen Egan
Journal:  Mar Drugs       Date:  2010-03-01       Impact factor: 5.118

9.  Antiviral activity of oxetanocins against varicella-zoster virus.

Authors:  T Sakuma; M Saijo; T Suzutani; I Yoshida; S Saito; M Kitagawa; S Hasegawa; M Azuma
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

10.  Comparative activity of various compounds against clinical strains of herpes simplex virus.

Authors:  G Andrei; R Snoeck; P Goubau; J Desmyter; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.